2008Zhongguo xiandai yixue/Zhongguo xiandai yixue zazhiRequires access

Clinical study of Montelukast combined with Loratadine on children suffered from cough variability asthma

Jinwen Wang

Open publisher page 0 citations

Abstract

Objective To observe the therapeutic efficacy of Montelukast combined with Loratadine on children suffered from cough variability asthma.MethodSixty-four children with cough variability asthma were randomly divided into two groups, children in control group(n =32) received Terbutaline sulphate and Ketotifen famarate oral-ly;while children in observation group(n =32) were treated with Montelukast and Loratadine orally.Treatment peroid in both groups 8 weeks, follow-up was conducted in 6 months after treatment.Result Effective rates were 93.7% in observation group and 59.3% in control group, respectively,the former was significantly higher than the latter(P 0.05).Recurrence rate in observation group was 6.2%(2/32), which was significantly lower than 34.3%(11/32) in control group(P 0.05).Conclusions The findings indicate that Montelukast combined with Loratadine is safe and effective for children suffered from cough variability asthma.

About this research paper

What this paper is about

Objective To observe the therapeutic efficacy of Montelukast combined with Loratadine on children suffered from cough variability asthma.MethodSixty-four children with cough variability asthma were randomly divided into two groups, children in control group(n =32) received Terbutaline sulphate and Ketotifen famarate oral-ly;while children in observation group(n =32) were treated with Montelukast and Loratadine orally.Treatment peroid in both groups 8 weeks, follow-up was conducted in 6 months after treatment.Result Effective rates were 93.7% in observation group and 59.3% in control group, respectively,the former was significantly higher than the latter(P 0.05).Recurrence rate in observation group was 6.2%(2/32), which was significantly lower than 34.3%(11/32) in control group(P 0.05).Conclusions The findings indicate that Montelukast combined with Loratadine is safe and effective for children suffered from cough variability asthma.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the therapeutic efficacy of Montelukast combined with Loratadine on children suffered from cough variability asthma.MethodSixty-four children with cough variability asthma were randomly divided into two groups, children in control group(n =32) received Terbutaline sulphate and Ketotifen famarate oral-ly;while children in observation group(n =32) were treated with Montelukast and Loratadine orally.Treatment peroid in both groups 8 weeks, follow-up was conducted in 6 months after treatment.Result Effective rates were 93.7% in observation group and 59.3% in control group, respectively,the former was significantly higher than the latter(P 0.05).Recurrence rate in observation group was 6.2%(2/32), which was significantly lower than 34.3%(11/32) in control group(P 0.05).Conclusions The findings indicate that Montelukast combined with Loratadine is safe and effective for children suffered from cough variability asthma.

Key concepts: Loratadine, Montelukast, Medicine, Asthma, Terbutaline, Ketotifen, Anesthesia, Pediatrics

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical study of Montelukast combined with Loratadine on children suffered from cough variability asthma — Research Paper | ScholarLens